PET of CXCR4 Expression by a 68Ga-Labeled Highly Specific Targeted Contrast Agent

Journal of Nuclear Medicine - China
doi 10.2967/jnumed.111.098798
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Society of Nuclear Medicine

Related search

Improving PET Quantification of Small Animal [68Ga]DOTA-Labeled PET/CT Studies by Using a CT-Based Positron Range Correction

Molecular Imaging and Biology
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2018English

Novel PET Imaging of Atherosclerosis With 68Ga-Labeled NOTA-Neomannosylated Human Serum Albumin

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2016English

[68Ga]-Hp-Do3a-Nitroimidazole: A Promising Agent for PET Detection of Tumor Hypoxia

Contrast Media and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2015English

68Ga-Labelled Exendin-3, a New Agent for the Detection of Insulinomas With PET

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2010English

Development of 68Ga- And 89Zr-Labeled Exendin-4 as Potential Radiotracers for the Imaging of Insulinomas by PET

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2015English

Reply To: Improved Scatter Correction to Eliminate Halo Artifacts for 68Ga-Labeled Radiopharmaceuticals in PET Imaging

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2019English

Optical Molecular Imaging of Lymph Nodes Using a Targeted Vascular Contrast Agent

Journal of Biomedical Optics
ElectronicOpticsMolecular Physics,OpticalBiomaterialsAtomicMagnetic MaterialsBiomedical Engineering
2005English

AMD3100: A Versatile Platform for CXCR4 Targeting 68Ga-Based Radiopharmaceuticals

English

Synthesis,68Ga-Radiolabeling, and PreliminaryIn VivoAssessment of a Depsipeptide-Derived Compound as a Potential PET/CT Infection Imaging Agent

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy